Moving Forward: Addimmune Research Continues at AGT

Addimmune is the HIV functional cure development project at American Gene Technologies (AGT).  You can find information on this site about our quest to develop a gene and cell therapy that is capable of providing people living with HIV (PLHIV) with durable remission from HIV with a single treatment.

Learn about AGT's work on gene and cell therapies for cancers and rare diseases at www.americangene.com:

Our Mission

Addimmune was born out of a deep sense of purpose—to bring an end to the suffering caused by HIV.

39,000,000+
people living with HIV globally
1,300,000+
new cases each year globally
SCIENCE

Pioneering a functional cure for HIV.

Our cell and gene therapy approach combines our knowledge of the HIV genome and human biology to create new opportunities to explore potential cures for HIV.

We envision a future where gene and cell therapies offer people a chance to move beyond the need for life-long treatments and finally conquer this virus."

JEFF GALVIN, CEO

Latest News